insomnia

Pear Therapeutics Looks For A Buyer As It Struggles To Get Paid For Prescription Apps
Pear Therapeutics Looks For A Buyer As It Struggles To Get Paid For Prescription Apps
Forbes
Pear Therapeutics
digital therapeutics
FDA
Medtech
insomnia
M&A
Flag link:
ResMed Strengthens Sleep Portfolio with Mementor Acquisition
ResMed Strengthens Sleep Portfolio with Mementor Acquisition
Medical Devices and Diagnostics Industry
ResMed
Mementor
insomnia
M&A
digital therapeutics
Flag link:
Idorsia's recently approved insomnia drug Quviviq hits the shelves
Idorsia's recently approved insomnia drug Quviviq hits the shelves
Bizjournals
Idorsia
drug launches
insomnia
Quviviq
Flag link:
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Fierce Pharma
Idorsia
Quviviq
insomnia
FDA
Merck
Belsomra
Flag link:
Idorsia hoping to make its dreams come true with a new insomnia alliance
Idorsia hoping to make its dreams come true with a new insomnia alliance
Fierce Pharma
Idorsia
insomnia
pharma marketing
daridorexant
Flag link:
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Pharmaforum
Eisai
Dayvigo
Japan
insomnia
Merck
Belsomra
Flag link:
Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Endpoints
Idorsia
daridorexant
insomnia
clinical trials
Flag link:
Idorsia's rival to Merck's insomnia drug clears phase 3 test
Idorsia's rival to Merck's insomnia drug clears phase 3 test
Fierce Biotech
Idorsia
Merck
insomnia
clinical trials
JNJ
daridorexant
Belsorma
Flag link:
Prescriptions for antidepressants, anti-anxiety, anti-insomnia drugs jumps 21% post COVID-19
Prescriptions for antidepressants, anti-anxiety, anti-insomnia drugs jumps 21% post COVID-19
Fierce Healthcare
Express Scripts
COVID-19
pandemic
prescription data
antidepressants
anxiety
insomnia
Flag link:
Merck's Insomnia Drug Approved for Alzheimer's Patients
Merck's Insomnia Drug Approved for Alzheimer's Patients
Motley Fool
Merck
FDA
Alzheimer's disease
Belsomra
insomnia
Flag link:
FDA clears Eisai’s insomnia drug Dayvigo
FDA clears Eisai’s insomnia drug Dayvigo
Pharmaforum
FDA
Eisai
Dayvigo
insomnia
Merck
Belsomra
Flag link:
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Eisai
Purdue
FDA
drug launches
insomnia
Dayvigo
Flag link:
Imbrium initiates phase 2 study of IMB-115 in insomnia associated with alcohol cessation
Imbrium initiates phase 2 study of IMB-115 in insomnia associated with alcohol cessation
Pharmaceutical Business Review
Imbrium Therapeutics
clinical trials
IMB-115
insomnia
IAAC
Flag link:
Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia
Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia
Endpoints
Minerva
insomnia
clinical trials
seltorexant
Flag link:
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
Merck Ready to Submit Belsomra to FDA for Alzheimer's Insomnia
BioSpace
Merck
Belsomra
insomnia
Alzheimer's disease
Flag link:
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Eisai
Purdue Pharma
insomnia
lemborexant
FDA
Flag link:
FDA adds boxed warnings to insomnia medicines following injuries, deaths
FDA adds boxed warnings to insomnia medicines following injuries, deaths
Endpoints
FDA
insomnia
black box
Lunesta
Sonata
Ambien
Ambien CR
Edluar
Intermezzo
Zolpimist
Flag link:
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
BioSpace
Eisai
Purdue Pharma
lemborexant
insomnia
Flag link:
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Indorsia
Actelion
JNJ
insomnia
Flag link:
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Fierce Biotech
Eisai
Purdue Pharma
lemborexant
sleep disorders
clinical trials
insomnia
Flag link:

Pages